Concepedia

Judith A. Smith

JA

70

Publications

3.3K

Citations

33

H-Index

1938

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

University of Pennsylvania

Memorial Hermann

University of Liverpool

Judith A. Smith is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and oncology.

ORCID

Top concepts

Publications per year

1938–2022

70

Publications

70

Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer

Charlotte C. Sun, Diane C. Bodurka, C. B. Weaver et al. · Supportive Care in Cancer · 2004 · 294 citations

, , +7

An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies

Marisa A. Navo, Julie Phan, Christy Vaughan et al. · Journal of Clinical Oncology · 2004 · 195 citations

Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy

Judith A. Smith, J. Yun Tso, Marcus R. Clark et al. · The Journal of Experimental Medicine · 1997 · 189 citations · Full text

Characterization of olanzapine-induced weight gain in rats

Andrew J. Goudie, Judith A. Smith, Jason C. G. Halford · Journal of Psychopharmacology · 2002 · 108 citations

Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by anvirzel and its cardiac glycoside component, oleandrin11Abbreviations: PARP, poly(ADP-ribose) polymerase; NF-κB, nuclear factor-κB; FGF-2, fibroblast growth factor-2; ER, endoplasmic reticulum; and MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.

Judith A. Smith, Timothy Madden, Mary Vijjeswarapu et al. · Biochemical Pharmacology · 2001 · 103 citations

, , +11

Rows per page

1–5 of 70